The Director-General of the World Health Organization, Tedros Adhanom Ghebreyesus, said Monday that the number of new Coronavirus infections worldwide increased last week for the first time in seven weeks. Tedros added that the increase is “disappointing, but not surprising.” He urged countries not to ease measures to combat the …
Read More »Moderna: We are Working on a Third Experimental Dose Targeting a New Mutated Strain of The Virus
“Moderna” revealed that it is working on a third experimental dose of the Coronavirus vaccine, targeting a new mutated strain of the virus. The company indicated that it shipped doses of the new vaccine to the National Institutes of Health for clinical trials, explaining that “Moderna is committed to making …
Read More »U.K. Warns New Coronavirus Variant Could be More Deadly
The Prime Minister of the United Kingdom (U.K.), Boris Johnson, said on Friday that the new variant of the novel Coronavirus, which caused a global pandemic, could be resulting in a higher mortality rate, Reuters reported. However, Johnson noted that studies have shown that the two vaccines that have been …
Read More »Britain Allows The Use of The Pfizer-BioNTech Vaccine
The United Kingdom has become the first country in the world to authorize the Pfizer and BioNTech coronavirus vaccine, making it available as of next week. “The government today accepted the MHRA recommendation to approve the use of the Pfizer-BioNTech Covid-19 vaccine,” the government said. And “the vaccine will be …
Read More »AstraZeneca Will Have 200 Million Doses of COVID-19 Vaccine by The End of The Year
Pam Cheng, chief operating officer at AstraZeneca, said that the company will have 200 million doses of its candidate vaccine, which it developed in cooperation with the University of Oxford, by the end of 2020, and that 700 million doses will be ready worldwide by the end of Q1 of …
Read More »Pfizer And BioNTech to Submit Emergency Use Authorization Request to FDA For COVID-19 Vaccine
Pfizer and BioNTech announced on Friday that they will be submitting an emergency use authorization request to the US Food and Drug Administration (FDA) on Friday. The shares of BioNTech and Pfizer increased by 6.3% and 1.5%, respectively, in the pre-opening trade on Wall Street. Today’s announcement came two days …
Read More »Pfizer and BioNTech: Vaccine 95% Effective in Final Efficacy Analysis of Phase 3 Trial
Pfizer Inc said on Wednesday that the final efficacy analysis of phase 3 trial of the coronavirus vaccine it develops with BioNTech has shown to be 95% effective, as reported by Reuters. “Efficacy of COVID-19 vaccine was consistent across age, race and ethnicity demographics.”“Planning to file for US emergency use …
Read More »Moderna Says Its COVID-19 Vaccine is 94.5% Effective
Moderna said its initial, third-beta data show its coronavirus vaccine is more than 94% effective in preventing Covid-19 – a result that CEO Stéphane Bancel has called it a “game-changer”. He added, “The thing that got me the most excited today was the severe disease.” Moderna, which developed its vaccine …
Read More »Risk Flows Started to Dominate Markets After Moderna Announces Longer Shelf Life For Vaccine
Risk flows started to dominate financial markets on Monday after Moderna announced that its COVID-19 vaccine candidate is expected to remain stable at standard refrigerator temperatures of 2° to 8°c for 30 days.
Read More »CureVac Planning to Produce 300-400 Million Vaccine Doses in 2021
German biotech CureVac’s CEO, Franz-Werner Haas, said on Thursday that they are planning to produce 300-400 million doses of their coronavirus vaccine in 2021, as reported by Reuters.
Read More »